Community Pharmacists' Role in Antidepressant Discontinuation: A Survey of Barriers and Facilitators
Basic & Clinical Pharmacology & Toxicology · 2026-04 · 138 (4)
DOI: 10.1111/bcpt.70226 ↗Kurz gefasst
Fachartikel in der Zeitschrift Basic & Clinical Pharmacology & Toxicology, online erschienen am 20.03.2026. Verfasst von Ketura Verheye und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic and Applied Medical Sciences, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium. Hauptthemen laut MEDLINE: Antidepressive Agents, Pharmacists, Professional Role, Community Pharmacy Services. Die Arbeit nennt 33 Literaturangaben.
Abstract (Originalsprache)
Background
Long‐term antidepressant use is widespread in high‐income countries. While general practitioners (GPs) are central in reviewing and discontinuing antidepressants, community pharmacists (CP) may support this process. However, barriers and facilitators to CP involvement remain underexplored.
Aim
This study aims to explore CPs' perceptions of long‐term antidepressant discontinuation and their roles in the antidepressants discontinuation process and to identify key barriers and facilitators for engaging in this process.
Methods
A cross‐sectional online survey was conducted among Belgian CPs. Items assessing perceived roles and barriers/facilitators were rated on Likert scales and categorized by mean scores.
Results
A total of 190 CPs completed the survey. Pharmacists identified their main responsibilities as informing patients, compounding tapering formulations and contacting physicians during tapering when problems arise. The only barrier classified as major was resistance from GPs to antidepressant discontinuation. Eleven major facilitators were identified, including patient‐initiated requests, good GP collaboration, strong trust relationships with patients and access to guidelines, information and education on discontinuation of antidepressants.
Conclusion
CPs currently tend to adopt a largely reactive approach towards discontinuing long‐term antidepressants. Interventions aiming to promote more proactive engagement may focus on clarifying roles and responsibilities, strengthening collaboration with GPs and supporting pharmacists through education, practical resources and communication training.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Basic and Applied Medical Sciences, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.
- Pharmaceutical Care Unit, Department of Bioanalysis, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium.
- Department of Public Health and Primary Care, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.
ORCID-Profile: Ketura Verheye, Ellen Van Leeuwen
Zitieren
APA
Verheye, K., Vangrieken, I., De Pril, K., Mehuys, E., Boussery, K., Christiaens, T., & Van Leeuwen, E. (2026). Community Pharmacists' Role in Antidepressant Discontinuation: A Survey of Barriers and Facilitators. Basic & Clinical Pharmacology & Toxicology, 138(4). https://doi.org/10.1111/bcpt.70226
Vancouver
Verheye K, Vangrieken I, De Pril K, Mehuys E, Boussery K, Christiaens T, et al. Community Pharmacists' Role in Antidepressant Discontinuation: A Survey of Barriers and Facilitators. Basic & Clinical Pharmacology & Toxicology. 2026;138(4). doi:10.1111/bcpt.70226
BibTeX
@article{Verheye2026,
author = {Verheye, Ketura and Vangrieken, Ine and De Pril, Kato and Mehuys, Els and Boussery, Koen and Christiaens, Thierry and Van Leeuwen, Ellen},
title = {Community Pharmacists' Role in Antidepressant Discontinuation: A Survey of Barriers and Facilitators},
journal = {Basic & Clinical Pharmacology & Toxicology},
year = {2026},
volume = {138},
number = {4},
doi = {10.1111/bcpt.70226}
}
EUVIMED